Appropriately aggregate holistic technologies via accurate expertise. Intrinsicly strategize worldwide initiatives and premium methodologies.
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials.
Journal article
Voysey M. et al, (2021), Lancet
Age and comorbidity are central to the risk of death from COVID-19 in liver transplant recipients.
Journal article
Webb GJ. et al, (2021), J Hepatol
Author Correction: Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2.
Journal article
Huo J. et al, (2021), Nature structural & molecular biology
Using an effective TB vaccination regimen to identify immune responses associated with protection in the murine model.
Journal article
Pinpathomrat N. et al, (2021), Vaccine
Individual-level variations in malaria susceptibility and acquisition of clinical protection
Journal article
Valletta JJ. et al, (2021), Wellcome Open Research, 6, 22 - 22
COVID-19 vaccines for rapid global impact.
Journal article
Hill AVS., (2021), BJU Int, 127, 137 - 139
Vi-specific serological correlates of protection for typhoid fever.
Journal article
Jin C. et al, (2021), The Journal of experimental medicine, 218
Heterologous vaccination regimens with self-amplifying RNA and Adenoviral COVID vaccines induce superior immune responses than single dose vaccine regimens in mice
Journal article
Spencer AJ. et al, (2021)
MAIT cell activation augments adenovirus vector vaccine immunogenicity
Journal article
Provine NM. et al, (2021), Science, 371, 521 - 526
Vaccines That Reduce Viral Shedding Do Not Prevent Transmission of H1N1 Pandemic 2009 Swine Influenza A Virus Infection to Unvaccinated Pigs.
Journal article
Everett HE. et al, (2021), Journal of virology, 95
SARS-CoV-2 infection in patients with autoimmune hepatitis.
Journal article
Marjot T. et al, (2021), Journal of hepatology
A COVID-19 vaccine candidate using SpyCatcher multimerization of the SARS-CoV-2 spike protein receptor-binding domain induces potent neutralising antibody responses.
Journal article
Tan TK. et al, (2021), Nature communications, 12
Meningococcal carriage in periods of high and low invasive meningococcal disease incidence in the UK: comparison of UKMenCar1-4 cross-sectional survey results.
Journal article
MacLennan JM. et al, (2021), The Lancet. Infectious diseases
Native-like SARS-CoV-2 spike glycoprotein expressed by ChAdOx1 nCoV-19/AZD1222 vaccine.
Journal article
Watanabe Y. et al, (2021), bioRxiv
Publisher Correction: ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques
Journal article
van Doremalen N. et al, (2021), Nature
ChAdOx1 nCoV-19 protection against SARS-CoV-2 in rhesus macaque and ferret challenge models
Journal article
Lambe T. et al, (2021)
Intranasal ChAdOx1 nCoV-19/AZD1222 vaccination reduces shedding of SARS-CoV-2 D614G in rhesus macaques.
Journal article
van Doremalen N. et al, (2021), bioRxiv
SARS-CoV-2 vaccination in patients with liver disease: responding to the next big question.
Journal article
Marjot T. et al, (2021), Lancet Gastroenterol Hepatol
Immunogenicity of the UK group B meningococcal vaccine (4CMenB) schedule against groups B and C meningococcal strains (Sched3): outcomes of a multicentre, open-label, randomised controlled trial.
Journal article
Davis K. et al, (2021), The Lancet. Infectious diseases
Mammalian expression of virus-like particles as a proof of principle for next generation polio vaccines.
Journal article
Bahar MW. et al, (2021), NPJ vaccines, 6